Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets.
This report contains market size and forecasts of Leukaphereis Product in Global, including the following market information:
Global Leukaphereis Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Leukaphereis Product market was valued at 23 million in 2021 and is projected to reach US$ 33 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Leukapheresis Disposables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leukaphereis Product include Asahi Kasei Medical, Fresenius, Haemonetics, Terumo BCT, Macopharma, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology, MEDICA and PuriBlood Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leukaphereis Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leukaphereis Product Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Leukaphereis Product Market Segment Percentages, by Type, 2021 (%)
Leukapheresis Disposables
Leukapheresis Devices
Global Leukaphereis Product Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Leukaphereis Product Market Segment Percentages, by Application, 2021 (%)
Research Applications
Therapeutic Applications
Global Leukaphereis Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Leukaphereis Product Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leukaphereis Product revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Leukaphereis Product revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Asahi Kasei Medical
Fresenius
Haemonetics
Terumo BCT
Macopharma
Miltenyi Biotec
Guangzhou Daji Medical Science and Technology
MEDICA
PuriBlood Medical
Charles River Laboratories
AllCells
StemExpress